MedTrace Logo

Adverse Effects of Ivermectin Used in Egypt During COVID-19

NCT04747678 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-02-10

No results posted yet for this study

Summary

retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt

Conditions

  • Covid19
  • Ivermectin Poisoning
  • Drug Toxicity
  • Drug Side Effect

Interventions

DRUG

Ivermectin

retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-03
Primary Completion
2021-02-28
Completion
2021-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04747678 on ClinicalTrials.gov